Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
101.80    0.00 (0.00%)
Bid:
82.00
Ask:
0.00
Spread: 21.40 (26.098%)
Market Cap: £166.89m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Interim Management Statement

12 May 2011 07:00

RNS Number : 4433G
Yule Catto & Co PLC
12 May 2011
 



12 May 2011

 

Yule Catto & Co plc (the "Group") 

 

Interim Management Statement

 

At this afternoon's AGM of Yule Catto & Co plc, the international producer of speciality chemicals, Chairman Peter Wood will make the following statement which also comprises the Group's interim management statement for the period 1 January 2011 to date.

 

The Group's earnings for the first quarter were well ahead of the same period last year excluding any impact of the PolymerLatex acquisition, and the Board's expectations for financial performance for 2011 remain unchanged.

 

Overall demand in Yule Catto's Polymer business was solid. Asian demand was strong through the quarter, whilst Europe firmed after a slow start in the UK. Ongoing very substantial monomer price increases have had to be passed on to customers, resulting in the usual temporary margin compression as the increases are recovered and target unit margins per tonne restored. Consequently, although volumes increased in Polymers and turnover was strongly ahead, operating profit was flat year on year in the first quarter. Whilst Europe lagged the prior year, Asia was ahead, despite, as expected, profits being temporarily constrained by capacity during the quarter. This position will be resolved in the course of the second quarter with the new 15,000 tonne nitrile expansion coming on line and some spare capacity in the acquired PolymerLatex nitrile assets. In April, the existing Yule Catto polymer business performed ahead of prior year.

 

The acquisition of PolymerLatex completed at the end of March as anticipated. Integration planning progressed through the first quarter and is now being implemented. Post acquisition, the synergy potential has been confirmed, and management remain highly confident that at least £20m of synergies will be delivered as disclosed at the time of the acquisition announcement and to the same timetable. Regular updates on progress in delivering these synergies will be provided to investors, with the first update to be delivered with the group's half year results in August. As at the date of this statement, actions taken to date have already delivered synergies with an annual run rate value of approximately £2m.

 

PolymerLatex itself traded comfortably ahead of last year in the first quarter, and this has continued through April. The business benefited from good demand in central Europe for latex and volume growth in its Malaysian nitrile facility. Plans are already being developed for very substantial increases in capacity in Asia for nitrile and SBR latex to be brought on line before the end of 2012.

 

In the Group's other businesses in the first quarter, the Pharma division performed well ahead of what was a very weak result in the same period last year, whilst William Blythe continued to grow profits strongly.

 

Net debt at the end of the quarter stood at £235m reflecting the impact of the acquisition of PolymerLatex, in line with the Group's forecasts at the time of the acquisition announcement.

 

- Ends -

 

ENQUIRIES:

 

Yule Catto & Co plc

Tel: 01279 442791

Adrian Whitfield, Chief Executive

David Blackwood, Group Finance Director

MHP Communications

Tel: 020 3128 8100

Andrew Jaques

John Olsen

Ian Payne

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSLFFLFERILLIL
Date   Source Headline
6th May 201011:00 amRNSInterim Management Statement
30th Apr 201012:40 pmRNSAnnual Information Update
8th Apr 20107:00 amRNSAnnual Financial Report
12th Mar 20107:00 amRNSDisposal
11th Mar 201010:32 amRNSDirector/PDMR Shareholding
11th Mar 201010:31 amRNSDirector/PDMR Shareholding
10th Mar 20107:00 amRNSFinal Results
11th Feb 201012:32 pmRNSHolding(s) in Company
4th Feb 201011:38 amRNSHolding(s) in Company
12th Jan 20107:00 amRNSTrading Update
25th Nov 200910:02 amRNSHolding(s) in Company
18th Nov 20099:28 amRNSHolding(s) in Company
19th Oct 20097:00 amRNSInterim Management Statement
2nd Sep 200910:14 amRNSHolding(s) in Company
24th Aug 20097:00 amRNSHalf Yearly Report
23rd Jun 20097:00 amRNSPre-close Trading Update
18th May 20099:16 amRNSDirector/PDMR Shareholding
14th May 200912:40 pmRNSResult of AGM
14th May 20097:00 amRNSAGM & Interim Management Statement
1st May 20097:00 amRNSAppointment of new joint brokers
21st Apr 20094:20 pmRNSAnnual Information Update
15th Apr 20099:24 amRNSAnnual Financial Report
23rd Mar 20094:03 pmRNSHolding(s) in Company
23rd Mar 20094:01 pmRNSHolding(s) in Company
20th Mar 200910:31 amRNSDirector/PDMR Shareholding
19th Mar 20097:00 amRNSAppointment of Senior Independent Director
16th Mar 20094:54 pmRNSDirector/PDMR Shareholding
12th Mar 20092:35 pmRNSDirector/PDMR Shareholding
12th Mar 20092:31 pmRNSDirector/PDMR Shareholding
11th Mar 20094:18 pmRNSDirector/PDMR Shareholding
11th Mar 20097:00 amRNSFinal Results
4th Mar 20094:35 pmRNSPrice Monitoring Extension
4th Mar 20091:57 pmRNSAppointment of non-executive director
13th Feb 20094:40 pmRNSSecond Price Monitoring Extn
13th Feb 20094:35 pmRNSPrice Monitoring Extension
30th Jan 20093:54 pmRNSNew Loan Facility / Completion of Disposal
21st Jan 20097:00 amRNSAppointment of new Chairman
19th Jan 20094:29 pmRNSDirector/PDMR Shareholding
15th Jan 20091:59 pmRNSDirector/PDMR Shareholding
13th Jan 200912:33 pmRNSHolding(s) in Company
7th Jan 20095:29 pmRNSDirector/PDMR Shareholding
5th Jan 200911:17 amRNSDisposal
29th Dec 20087:00 amRNSUpdate
12th Dec 200810:08 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSSale of PFW Aroma Chemicals BV
3rd Dec 200810:57 amRNSBlocklisting Interim Review
20th Nov 20084:47 pmRNSSecond Price Monitoring Extn
20th Nov 20084:39 pmRNSPrice Monitoring Extension
14th Nov 20087:00 amRNSInterim Management Statement
10th Nov 20083:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.